期刊文献+

Fra-1对大鼠C6胶质瘤细胞侵袭转移能力的影响

Effects of Fra-1 on Invasive Ability of C6 Glioma Cells
原文传递
导出
摘要 目的:观察Fra-1对C6胶质瘤侵袭转移能力的影响。方法:以大鼠C6胶质瘤细胞为研究对象,Fra-1 siRNA通过脂质体转染C6,realtime RT-PCR和western blot法检测C6细胞中Fra-1的表达、Elisa法检测细胞培养上清中MMP-9的含量,Transwell小室观察C6细胞的转移侵袭能力。结果:干扰Fra-l后能降低C6细胞中Fra-1的表达,显著降低C6细胞中MMP-9的含量,降低C6细胞的转移侵袭能力。结论:干扰Fra-1能抑制C6细胞的转移侵袭。 Objective: To study the effect ofFra-lon invasive ability of C6 cells. Methods: C6 cells were divide into blank group, control group, Fra-lsiRNA groups. The effects of Fra-I siRNA on C6 cells invasive ability in vitro was measured by Boyden chamber invasive models. Contents of Fra-1 protein and mRNA were detected by western blot and realtime RT-PCR, respectively. Contents of MMP-9 were measured by ELISA methods. Results: In siRNA group, contents of Fra-1 and MMP-9 were decreased markedly, the invasive ability was decreased markedly, too. Conclusion: Fra-1 siRNA could decrease the invasive ability of C6 cell.
出处 《现代生物医学进展》 CAS 2011年第16期3038-3040,共3页 Progress in Modern Biomedicine
关键词 Fra-1 基质金属蛋白酶 C6 Fra-1 Matrix metalloproteinase C6
  • 相关文献

参考文献18

  • 1Adiseshaiah P, Lindner DJ, Kalvakolanu DV, et al. FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo[J]. Cancer Res, 2007, 67(13): 6204-6211.
  • 2Samoylenko A, Dimova EY, Horbach T et al. Opposite expression of the antioxidant heme oxygenase-I in primary cells and tumor cells: regulation by interaction of USF-2 and Fra-1 [J]. Antioxid Redox Signal, 2008, 10(7): 1163-1174.
  • 3Luo YP, Zhou H, Krueger Jet al. The role ofproto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression[J]. Oncogene, 2010, 29(5): 662-673.
  • 4Adiseshaiah P, Li J, Vaz Met al. ERK signaling regulates tumor promoter induced c-Jun recruitment at the Fra-1 promoter [J]. Biochem Biophys Res Commun., 2008, 371 (2): 304-308.
  • 5Das KC, Muniyappa H. c-Jun NH2 terminal kinase (JNK)-mediates AP-1 activation by thioredoxin: phosphorylation of cJun, JunB, and Fra-1 [J]. Mol Cell Bioehem, 2010, 337(1-2): 53-63.
  • 6Nakajima H, Mizuta N, Sakaguchi K, et al. Aberrant expression of Fra-1 in estrogen receptor-negative breast cancers and suppression of their propagation in vivo by ascochlorin, an antibiotic that inhibits cellular activator protein-1 activity [J]. J Antibiot (Tokyo), 2007, 60 (11): 682-689.
  • 7Fan Y, Yu Y, Shi Y, et al. Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha- and interleukin-lbeta-induced IKK/NF-kappaB and JNK/AP-1 activation [J]. J Biol Chem, 2010, 285(8): 5347-5360.
  • 8Yin Y, Wang S, Sun Y, et al. JNK/AP-I pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells [J]. Biomed Pharmacother, 2009, 63(6): 429-435.
  • 9Jacques E, Semlali A, Boulet LP, et al. AP-1 overexpression impairs corticosteroid inhibition of collagen production by fibroblasts isolated from asthmatic subjects [J]. Am J Physiol Lung Cell Mol Physiol, 2010, 299(2): L281-287.
  • 10Sen T, Dutta A, Chatterjee A, et al. Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231 [J]. Anticancer Drugs, 2010, 21 (6): 632-644.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部